secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2025-07-21T23:59:59+00:00
Accession:  0001628280-25-035424
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology appoints Robert Brainin as CEO effective Aug 25, 2025
------------------------------------------------------------------------

- Robert Brainin named CEO, effective August 25, 2025; he was a Board member since Feb 2021.
- Annual base salary of $500,000; target incentive bonus of 75% of base salary.
- Equity awards: 225,000 options (4-year vest) and 475,000 performance-based options.
- Ronnie Morris, M.D., transitions to Executive Chairman; Joel Ackerman becomes Director.
- Brainin brings 25+ years life sciences/tech experience; most recently CBO at Veracyte.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828025035424/0001628280-25-035424-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828025035424/csbr-20250721.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-035424

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer